Introduction: The added value of dopamine transporter SPECT (DAT-SPECT) for the diagnosis of "possible" multiple system atrophy of the cerebellar type (MSA-C) remains unknown.
Methods: We reviewed retrospectively the charts of 128 consecutive patients with a clinical diagnosis of MSA-C who were seen between 2007 and 2016 at the French Reference Center for MSA. The main objective was to evaluate the proportion of patients for whom the diagnosis of "possible" MSA-C was made because of a positive DAT-SPECT.
Results: Seventy-eight MSA-C patients had at least one DAT-SPECT. Fifty-nine of them were considered for the final analysis. In these, 22 had "possible" MSA-C and 23 "probable" MSA-C before DAT-SPECT, while 14 did not reach diagnosis criteria at that time. In those with "possible" MSA-C, DAT-SPECT was positive in 64%. In patients with "probable" MSA-C, 83% showed nigrostriatal denervation. Six out of 14 (43%) received a diagnosis of "possible" MSA-C because of positive DAT-SPECT. These patients had mean disease duration of 2.3 years at the time of DAT-SPECT compared to 3.5 years of the entire cohort of MSA-C patients with DAT-SPECT. Of the eight remaining, one had positive DAT-SPECT but also pons atrophy on magnetic resonance imaging, and seven progressed to "probable" MSA based on clinical features.
Conclusion: Our results suggest that DAT-SPECT significantly contributes to the diagnosis of "possible" MSA-C (43% of patients not reaching consensus diagnosis criteria before DAT-SPECT). DAT-SPECT seems especially useful in patients with shorter disease duration, while a negative result does not exclude a diagnosis of MSA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.parkreldis.2019.02.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multiple System Atrophy Masquerading as Drug-Resistant Orthostatic Hypotension.
Cureus
September 2024
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, JPN.
Article Synopsis
- A 54-year-old man experienced recurrent fainting spells (syncope) for two years, which didn't respond to medications like droxidopa and amezinium.
- After several tests showed no clear cause, a positive Schellong test pointed to orthostatic hypotension as a likely diagnosis, along with mild cerebellar ataxia noted during neurological evaluation.
- MRI results suggested a "cross sign" in the pons, and further imaging indicated reduced dopamine uptake, leading to a diagnosis of probable multiple system atrophy of the cerebellar type (MSA-C), prompting treatment with taltirelin hydrate.
Sleep disturbances in probable multiple system atrophy.
Sleep Med
December 2024
Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India. Electronic address:
Article Synopsis
- Multiple system atrophy (MSA) is a serious neurodegenerative disorder that significantly disrupts sleep, impacting the overall quality of life for patients and serving as a negative prognostic factor.
- The study investigated sleep disturbances in 60 probable MSA patients in India, revealing a high prevalence of issues like REM behavior disorder, poor sleep quality, and insomnia, with poor sleep correlating to disease severity.
- Findings suggest that the type of MSA (parkinsonian vs. cerebellar) does not notably affect sleep parameters, but the duration of REM behavior disorder is linked to worse sleep quality and disease progression.
Clinical Application of 18 F-THK5351 PET to Image Ongoing Astrogliosis in MSA-P and MSA-C.
Clin Nucl Med
October 2024
From the Department of Neurology.
18 F-labeled THK5351 PET can visualize ongoing astrogliosis by estimating monoamine oxidase B levels and can be used as an adjunct for diagnosing neurodegenerative disorders. Little has been reported on multiple system atrophy (MSA) in the differential diagnosis of parkinsonian syndromes. Here, we present 18 F-THK5351 images in typical cases of MSA-P (parkinsonian type) and MSA-C (cerebellar type), showing intense 18 F-THK5351 uptake in the lateral-posterior part of the putamen (MSA-P) and in the pons and middle cerebellar peduncles (MSA-C).
View Article and Find Full Text PDFThe genetic landscape and phenotypic spectrum of GAA-FGF14 ataxia in China: a large cohort study.
EBioMedicine
April 2024
Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China; Department of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, China; Bioinformatics Center & National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China; Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China; National International Collaborative Research Center for Medical Metabolomics, Central South University, Changsha, Hunan, China; Furong Laboratory, Central South University, Changsha, Hunan, 410008, China; Brain Research Center, Central South University, Changsha, Hunan, 410008, China. Electronic address:
Background: An intronic GAA repeat expansion in FGF14 was recently identified as a cause of GAA-FGF14 ataxia. We aimed to characterise the frequency and phenotypic profile of GAA-FGF14 ataxia in a large Chinese ataxia cohort.
Methods: A total of 1216 patients that included 399 typical late-onset cerebellar ataxia (LOCA), 290 early-onset cerebellar ataxia (EOCA), and 527 multiple system atrophy with predominant cerebellar ataxia (MSA-c) were enrolled.
Rates of change of pons and middle cerebellar peduncle diameters are diagnostic of multiple system atrophy of the cerebellar type.
Brain Commun
February 2024
Ataxia Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Definitive diagnosis of multiple system atrophy of the cerebellar type (MSA-C) is challenging. We hypothesized that rates of change of pons and middle cerebellar peduncle diameters on MRI would be unique to MSA-C and serve as diagnostic biomarkers. We defined the normative data for anterior-posterior pons and transverse middle cerebellar peduncle diameters on brain MRI in healthy controls, performed diameter-volume correlations and measured intra- and inter-rater reliability.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!